Pakistan: Losartan, a widely used angiotensin II receptor blocker for hypertension, has recently been recognized for its ...

Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...

ANSWER: Although most people think that asthma causes wheezing, cough is a very common symptom of asthma. You’ve named the ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

HOLDINGS has completed a draw on its Equity Line of Credit to support the commercial launch of Arbli Oral Suspension, while ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers ...

Scienture shares originally traded higher on Tuesday but have since reversed and began trading lower after the company ...

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that the Company will ...

Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...

Losartan (Cozaar) is a generic drug that is prescribed for certain conditions, including high blood pressure. Losartan comes as an oral tablet and belongs to the angiotensin II receptor blocker ...